title: Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?
authors.affiliation: a Department of Medicine , University of Washington , Seattle , WA , USA ;
authors.forename: Daisuke
authors.initials: D
authors.lastname: Araki
authors.affiliation: b Public Health Sciences Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA ;
authors.forename: Megan
authors.initials: M
authors.lastname: Othus
authors.affiliation: c Department of Medicine, Division of Hematology , University of Washington , Seattle , WA , USA ;|d Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.
authors.forename: Roland B
authors.initials: RB
authors.lastname: Walter
authors.affiliation: c Department of Medicine, Division of Hematology , University of Washington , Seattle , WA , USA ;|d Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.
authors.forename: Pamela S
authors.initials: PS
authors.lastname: Becker
authors.affiliation: d Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.
authors.forename: Vicky
authors.initials: V
authors.lastname: Sandhu
authors.affiliation: c Department of Medicine, Division of Hematology , University of Washington , Seattle , WA , USA ;|d Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.
authors.forename: Elihu H
authors.initials: EH
authors.lastname: Estey
mesh_terms: D019008:Drug Resistance, Neoplasm; D006801:Humans; D053208:Kaplan-Meier Estimate; D015470:Leukemia, Myeloid, Acute / Q000401:mortality* / Q000473:pathology / Q000628:therapy*; D012008:Recurrence; D016879:Salvage Therapy; D016896:Treatment Outcome